Overview

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is a double-masked, placebo-controlled study which will determine the action of NCX 470 ophthalmic solution, 0.1% on aqueous humor dynamic parameters in healthy volunteers or subjects with OHT.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nicox Ophthalmics, Inc.
Treatments:
Bimatoprost
Lubricant Eye Drops
Nitric Oxide